Best Hospitals for Diffusive-toxic goiter treatment in Republic of Korea 2026

Primary treatment for diffuse toxic goiter in South Korea centers on pharmacological therapy using antithyroid drugs. Nearly 98% of patients receive methimazole as the initial medical intervention. Secondary options include thyroidectomy and radioactive iodine therapy for patients who experience recurrence or specific clinical complications.

• Antithyroid drugs: Preferred first-line therapy used in approximately 98% of South Korean cases.
• Thyroidectomy: Surgical removal offered at high-volume centers for relapsed or complex cases.
• Radioactive iodine: Non-surgical definitive treatment used in less than 1% of initial cases.
• Management strategy: Clinicians often prescribe a second course of medication before considering surgery.

Bookimed Expert Insight: Patient volume serves as a critical quality indicator in Seoul. Asan Medical Center manages over 10,000 outpatients daily and performs 65,000+ operations annually. Choosing such high-capacity facilities ensures access to multidisciplinary teams experienced in managing the 58% recurrence rate common with medication-only protocols.

Patient Consensus: Patients note that South Korean surgeons are highly experienced with thyroid procedures. Many prefer starting with medication to avoid the lifelong hormone replacement therapy required after surgery or radiation.

South Korean specialists recommend thyroidectomy when patients require immediate hormonal stabilization or have large goiters causing compression. It is preferred for suspected malignancy, failed medication therapy, or severe drug reactions. JCI-accredited centers in Seoul report lower relapse rates of 3% to 8% compared to other therapies.

• Large goiters: Surgery addresses breathing or swallowing difficulties caused by significant gland enlargement.
• Treatment failure: Thyroidectomy is definitive when patients relapse after 12–18 months of medication.
• Ocular health: Surgery is preferred over radioactive iodine for patients with active eye disease.
• Aesthetic concerns: Specialized clinics like Ewha Womans University Medical Center offer minimally invasive, scarless techniques.

Bookimed Expert Insight: While antithyroid drugs are the standard first-line choice in South Korea, the decision to operate is often driven by physical symptoms rather than just lab results. Data from high-volume centers like Asan Medical Center, which handles over 65,000 operations annually, suggests that surgery is the fastest path to resolution for patients with large, visible glands that do not respond to iodine or drugs.

Patient Consensus: Patients often choose surgery because it provides immediate relief from neck tightness and swallowing issues that radioactive iodine cannot fix quickly.

Preparation in South Korea includes a strict low-iodine diet for 10–14 days and pausing antithyroid medications. Leading Seoul centers like Ewha Womans University Medical Center require high TSH levels before treatment. Patients must confirm negative pregnancy status and stop breastfeeding 6 weeks prior.

• Dietary restrictions: Stop iodine-rich foods like seaweed, seafood, and dairy for 2 weeks.
• Medication pause: Stop methimazole or propylthiouracil 7 days before your scheduled appointment.
• TSH elevation: Receive thyrotropin alfa injections over 2 days to boost iodine absorption.
• Safety protocols: Plan for 3–5 days of isolation following the radioactive dose administration.

Bookimed Expert Insight: Korea ranks 2nd globally for medical travel on Bookimed. Digital-first facilities like Seoul National University Bundang Hospital use integrated electronic systems to track prep. Large centers often manage 10,000+ daily patients. This high volume ensures exceptionally standardized and efficient nuclear medicine protocols.

Patient Consensus: Patients note that avoiding hidden iodine in restaurant food and sauces is challenging. Many mention a temporary increase in tremors or anxiety after stopping antithyroid medications.

Seoul is home to globally recognized centers for thyroid care, including Seoul National University Hospital, Asan Medical Center, and Samsung Medical Center. These facilities are certified by the Joint Commission International and repeatedly listed among the World's Best Hospitals by Newsweek for their endocrine surgery excellence.

• Asan Medical Center: Serves 11,800+ outpatients daily and manages complex endocrine cases in Seoul.
• Severance Hospital: Features an international multidisciplinary clinic treating over 1.6 million outpatients annually.
• Ewha Womans University: Provides specialized thyroid cancer treatments focusing on aesthetic results with minimal scarring.
• SNU Bundang Hospital: Uses a digital BESTcare system to enhance patient safety during surgical procedures.

Bookimed Expert Insight: While general reputation is strong across Seoul, surgical volume varies significantly between these top-tier institutions. Data suggests focusing on clinics like Asan Medical Center or Severance Hospital. These centers handle massive clinical loads that often lead to higher success rates for complex diffusive-toxic goiter procedures. Choosing a facility that treats over 1,500,000 patients annually ensures access to surgeons with peak technical experience.

Patient Consensus: Patients note that major university hospitals in Seoul provide efficient diagnostics but emphasize the importance of having a dedicated endocrine surgery team. Many suggest prioritizing the surgeon's personal experience with goiter over the hospital's general brand name.

Patients follow-up for diffuse toxic goiter requires thyroid function tests every 4 weeks during the first 3 months. Long-term monitoring occurs every 2–3 months for up to 3 years. Post-surgical or radiation patients need lifelong annual TSH checks to manage hormone replacement levels.

• Initial medication monitoring: Blood tests are required every 4 weeks for the first 3 months.
• Maintenance drug phase: Check-ups occur every 2–3 months for the following 18–36 months.
• Post-radioiodine care: Free T4 and T3 levels require monitoring every 4–6 weeks for 6 months.
• Long-term surveillance: Stable patients transition to annual TSH testing to prevent undiagnosed hypothyroidism.

Bookimed Expert Insight: Leading Seoul facilities like Seoul National University Hospital and Severance Hospital use integrated digital systems to track lab trends. These centers handle over 1,000,000 patients annually. This high volume means they often detect relapse patterns earlier than lower-volume clinics. Patients should utilize these digital records to ensure seamless dose adjustments during the critical first year.

Patient Consensus: Patients emphasize that you cannot rely on how you feel alone. Regular lab tests for TSH, free T4, and T3 are the only way to catch late-onset hypothyroidism after surgery.

South Korea uses radioactive iodine less frequently for hyperthyroidism than the United States, with over 97% of Korean patients receiving antithyroid drugs first. However, major Seoul centers like Severance Hospital and Asan Medical Center provide high-volume radioactive iodine therapy for thyroid cancer using specialized isolation protocols.

• Treatment preference: Most Korean endocrinologists prioritize medication over radioactive iodine for hyperthyroidism cases.
• Cancer applications: Specialized facilities often use iodine-131 for thyroid cancer following surgical tumor removal.
• Accreditation standards: Top hospitals maintain Joint Commission International (JCI) and KOIHA certifications for nuclear medicine safety.
• Isolation protocol: High-dose therapy requires specialized inpatient rooms available at major multidisciplinary academic centers.

Bookimed Expert Insight: While general data suggests lower usage, Korea's top-tier hospitals demonstrate massive clinical experience with radioactive iodine. For example, Asan Medical Center and Seoul National University Hospital serve over 10,000 patients daily. This high volume allows these digital hospitals to use advanced tracking systems for precise dose monitoring and faster recovery.

Patient Consensus: Patients note that doctors often view radioactive iodine as a reliable standard option when medications fail. They frequently emphasize that preparing for the required low-iodine diet and temporary isolation are the most challenging parts of the process.